This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other disorders of thyroid
DIS_THYROID_OTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
472 |
6. Filter based on genotype QC (FinnGen only) |
472 |
Control definitions (FinnGen only)
- Control exclude
- THYROID_DISORDER_IBD
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other disorders of thyroid
based on the number of shared cases.
Similar with more cases:
- Disorders of thyroid, IBD co-morbidities
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 472 | 389 | 83 |
| Unadjusted period prevalence (%) | 0.12 | 0.13 | 0.04 |
| Median age at first event (years) | 43.99 | 42.16 | 52.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 401
- Matched controls
- 4011
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
1274.9
173.6
157
*
24599
ICD-8 Finland
Thyroiditis, Unspecified
+∞
138.8
125
*
E07.89
ICD-10 Finland
Other specified disorders of thyroid
+∞
74.3
69
*
H03AA01
ATC
levothyroxine sodium; systemic
4.9
45.4
198
662
104
Kela drug reimbursment
Thyroid insufficiency
6.9
32.9
89
160
H03BB01
ATC
carbimazole; oral
74.8
25.1
28
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
116.0
20.8
22
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
7.5
19.2
46
68
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.7
18.1
89
290
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
94.0
16.7
18
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
8.7
16.7
36
45
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
166.1
15.6
16
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
7.4
13.9
33
48
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
9.0
13.5
28
33
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
8.4
12.5
27
34
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
13.0
12.3
21
17
BAA60
NOMESCO Finland
Total thyroidectomy
9.7
12.2
24
26
E07.81
ICD-10 Finland
Pituitary thyroxin resistence
+∞
10.5
10
*
E07.82
ICD-10 Finland
Disorder of thyroid function caused by general disease state
+∞
10.5
10
*
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
10.5
10
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
12.6
9.9
17
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.9
9.2
38
106
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
16.0
9.1
14
9
2469X
ICD-9 Finland
Other disorders of thyroid, Unspecified disorder of thyroid
+∞
8.4
8
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
+∞
8.4
8
*
E07.8
ICD-10 Finland
Other specified disorders of thyroid
+∞
8.4
8
*
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
+∞
7.3
7
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
7.2
7.1
16
23
T86
ICPC
Hypothyroidism/myxoedema
3.8
6.9
28
78
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
40.7
6.8
8
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
6.4
6.5
16
26
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
6.4
151
1025
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
+∞
6.3
6
*
E07.80
ICD-10 Finland
Pituitary thyroxin resistence
+∞
6.3
6
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.1
120
764
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
6.2
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
192
6.58
55.39
4.1
2.2
4.6
4.4
pmol/l
1.00
98
162
47
56
9.21
37.10
2.2
1.1
2.5
2.6
iu/l
—
19
9
400
3165
2.73
14.37
7.6
3.9
15.6
14.7
pmol/l
6.20
381
2860
71
280
2.81
12.93
1.4
1.2
123.4
129.4
iu/ml
0.05
27
111
273
1918
2.00
12.11
8.1
5.9
1.2
1.2
mmol/l
0.14
239
1623
20
33
6.28
11.75
5.7
4.7
42.5
49.0
u/ml
0.10
11
13
426
3671
2.65
9.46
8.8
4.8
1.9
1.9
mu/l
0.09
405
3339
150
919
1.93
9.38
2.1
2.1
—
—
—
0
0
75
355
2.32
9.25
2.3
1.9
377.1
374.2
nmol/l
0.04
70
324
33
101
3.44
9.21
1.2
1.2
—
—
—
0
0
243
1757
1.79
8.76
7.7
5.1
1.2
1.2
mmol/l
0.32
224
1588
361
2958
1.94
8.46
4.9
4.2
12.2
12.2
mm/h
0.01
342
2718
245
1810
1.74
7.91
4.1
3.8
—
—
—
0
0
194
1371
1.70
7.15
3.0
3.3
2.3
2.4
mmol/l
0.91
175
1191
112
691
1.81
6.56
3.6
3.6
764.0
192.1
ng/l
0.38
74
517
72
386
2.02
6.43
2.1
2.2
5.7
6.9
umol/l
0.50
63
329
59
306
2.06
5.76
2.6
3.2
69.3
79.2
ng/l
0.59
51
271
225
1729
1.58
5.52
2.7
2.3
78.6
78.6
nmol/l
0.01
208
1533
211
1610
1.56
5.27
2.3
2.0
101.7
95.6
pmol/l
0.99
110
759
348
3018
1.58
4.57
7.4
7.0
75.3
76.1
u/l
0.19
334
2801
110
746
1.62
4.42
1.8
1.7
993.7
1239.1
nmol/l
1.67
91
549
211
1658
1.49
4.35
4.7
4.1
36.7
35.7
g/l
1.94
199
1532
87
576
1.63
3.83
2.1
2.8
2.7
3.6
e6/l
0.42
39
282
10
25
4.06
3.71
1.5
1.2
2.3
2.0
mmol/l
—
10
25
263
2213
1.43
3.52
6.4
4.2
6.6
6.6
mmol/l
0.03
246
2040
427
3974
1.78
3.41
19.9
15.1
139.5
139.7
mmol/l
0.88
418
3847
420
3899
1.70
3.28
16.1
13.3
20.1
21.9
mg/l
0.52
346
3038
427
3982
1.76
3.27
20.2
15.2
3.9
3.9
mmol/l
0.40
417
3847
100
720
1.49
3.02
1.3
1.3
15.3
11.9
u/ml
0.15
41
268
307
2696
1.40
2.98
5.0
4.7
6.0
3219.6
e6/l
—
5
40
409
3794
1.58
2.93
5.2
4.5
5.9
5.9
mmol/l
0.35
383
3451
17
70
2.48
2.91
2.3
3.0
4.7
4.6
e9/l
0.07
17
70
144
1119
1.41
2.90
2.8
2.9
805.5
1020.9
ng/l
0.75
119
944
17
71
2.45
2.83
2.3
3.3
61.3
59.0
%
0.35
17
71
147
1154
1.40
2.78
2.4
2.0
124.3
179.6
u/l
1.68
136
1092
20
94
2.18
2.58
1.8
2.1
178.2
184.0
%
0.14
20
88
259
2244
1.34
2.56
8.1
8.8
3.9
4.0
e9/l
0.61
230
1974
87
632
1.46
2.50
2.1
2.5
0.9
1.0
e6/l
0.35
39
334
13
51
2.59
2.46
1.4
1.3
0.5
0.6
nmol/l
1.12
13
45
103
776
1.42
2.44
3.3
2.7
2.4
2.5
mmol/l
0.76
88
681
53
351
1.57
2.35
2.5
2.1
32.6
32.6
u/l
0.00
45
290
7
19
3.72
2.16
1.0
1.2
—
—
—
0
0
164
1357
1.32
2.13
3.0
3.1
—
—
—
0
0
58
402
1.50
2.11
13.0
6.0
13.0
12.1
kpa
0.59
53
386
58
402
1.50
2.11
13.1
6.0
5.0
5.1
kpa
0.70
53
386
124
986
1.35
2.11
2.2
2.1
2.8
3.1
mg/l
0.62
104
833
28
161
1.79
2.11
1.5
1.4
26.5
28.3
iu/l
0.10
22
139
9
31
2.94
2.08
1.1
1.3
—
—
—
0
0
120
953
1.35
2.05
2.2
2.6
2794.5
7614.6
umol/l
0.97
95
821
209
1795
1.29
2.04
3.7
2.8
106.8
99.0
ug/l
0.13
192
1651
111
872
1.36
2.04
1.8
1.7
1.2
1.0
mg/l
0.16
78
661
11
44
2.54
2.02
1.1
1.1
—
—
—
0
0
15
70
2.18
2.00
1.4
1.5
—
—
—
0
0
131
1059
1.33
1.98
2.8
2.9
0.2
0.4
e6/l
1.87
90
790
98
758
1.37
1.98
1.4
1.3
19.4
36.3
iu/ml
1.27
25
229
405
3821
1.42
1.93
4.5
4.4
4.7
4.8
mmol/l
0.43
380
3516
80
601
1.40
1.93
1.6
1.9
—
—
—
0
0
57
402
1.48
1.92
13.2
6.1
1.1
1.5
mmol/l
0.24
44
320
21
114
1.88
1.90
2.3
1.7
—
—
—
0
0
147
1215
1.30
1.89
3.1
2.2
58.9
56.7
u/l
0.16
137
1122
25
144
1.78
1.89
1.7
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
22
3.21
1.88
1.0
1.2
—
—
—
0
0
428
4086
1.51
1.85
19.0
15.6
75.2
72.5
umol/l
0.62
428
4086
279
2506
1.28
1.85
3.7
2.9
49.0
42.8
u/l
0.58
264
2316
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
12
4.20
1.82
1.2
2.0
155.4
115.4
%
—
5
12
35
224
1.61
1.82
1.4
1.7
—
—
—
0
0
381
3569
1.35
1.81
6.2
5.7
39.0
39.4
mmol/mol
0.42
361
3301
13
60
2.20
1.79
1.2
1.0
0.7
2.6
u/ml
—
5
28
267
2391
1.27
1.79
3.2
3.1
—
—
—
0
0
402
3802
1.39
1.76
4.4
4.3
1.5
1.6
mmol/l
0.85
373
3483
233
2058
1.26
1.73
5.2
5.5
10.6
10.2
umol/l
0.35
218
1937
17
91
1.90
1.62
1.3
1.3
—
11.9
—
0
8
93
736
1.33
1.62
1.6
1.5
—
—
—
0
0
10
43
2.35
1.61
1.1
1.1
—
—
—
0
0
429
4117
1.46
1.59
11.5
10.1
24.3
23.9
u/l
0.23
417
3944
66
498
1.38
1.56
4.0
4.3
32.5
32.7
%
0.06
53
311
371
3486
1.30
1.55
19.1
14.3
38.5
39.2
%
0.66
278
2462
8
33
2.45
1.54
1.4
1.2
—
72.2
—
0
5
409
3899
1.37
1.52
5.2
4.9
2.7
2.8
mmol/l
0.49
382
3567
60
448
1.39
1.52
18.2
19.8
1.5
1.2
inr
0.71
13
56
5
16
3.15
1.44
1.8
2.4
—
—
—
0
0
40
280
1.47
1.44
1.5
1.5
—
—
—
0
0
387
3671
1.30
1.40
15.4
12.5
80.2
80.5
ml/min/173m2
0.09
330
2981
54
402
1.39
1.40
3.1
3.7
55.9
17.4
ug/l
0.32
45
338
24
151
1.62
1.37
1.7
2.1
—
—
—
0
0
5
17
2.96
1.36
2.0
1.5
—
—
—
0
0
100
823
1.27
1.31
1.7
1.7
498.3
10767412.9
pmol/l
0.50
84
678
17
99
1.74
1.29
1.6
1.3
442.5
465.6
mg/l
0.13
17
92
5
18
2.80
1.29
1.2
1.5
—
—
—
0
0
16
92
1.77
1.26
1.3
1.2
—
—
—
0
0
8
36
2.24
1.25
1.3
1.1
—
—
—
0
0
55
421
1.35
1.22
1.7
1.8
—
—
—
0
0
112
944
1.24
1.20
1.5
1.5
21.0
21.8
nmol/l
0.24
97
797
15
87
1.75
1.16
3.3
3.8
15.9
25.6
mg/l
—
9
51
55
425
1.33
1.15
1.7
1.8
—
—
—
0
0
220
1991
1.20
1.15
4.0
3.9
0.0
0.0
estimate
0.00
33
392
143
1243
1.22
1.14
3.2
2.8
26.7
29.2
u/l
1.45
134
1181
111
940
1.24
1.14
1.4
1.3
0.8
2.1
u/ml
1.48
23
258
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
7
32
2.20
1.08
2.1
2.3
—
—
—
0
0
16
97
1.67
1.08
1.3
1.4
—
—
—
0
0
15
90
1.69
1.05
1.5
1.2
3.4
3.8
mmol/l
1.05
15
82
11
60
1.85
1.03
1.5
2.0
—
—
—
0
0
10
53
1.91
1.02
1.2
1.1
—
—
—
0
0
94
1102
0.82
0.99
4.7
4.3
0.0
0.0
estimate
0.00
35
384
42
321
1.34
0.97
4.0
3.1
1.4
2.2
mmol/l
0.80
36
246
43
330
1.33
0.97
16.4
6.5
120.6
120.6
g/l
0.01
38
322
11
63
1.76
0.91
1.8
1.3
—
—
—
0
0
25
178
1.43
0.88
2.9
2.3
1.2
1.2
%
0.00
25
178
39
500
0.76
0.88
6.1
7.1
—
—
—
0
0
8
43
1.87
0.87
3.4
3.7
—
—
—
0
0
6
30
2.01
0.87
1.5
1.1
—
—
—
0
0
32
241
1.35
0.83
1.4
1.8
—
—
—
0
0
12
73
1.66
0.82
1.5
1.3
—
—
—
0
0
12
73
1.66
0.82
1.5
1.3
—
—
—
0
0
219
2025
1.15
0.80
4.1
3.9
0.0
0.0
estimate
0.50
37
387
15
98
1.55
0.79
8.8
2.0
3.2
3.7
g/l
1.31
15
93
5
24
2.09
0.74
2.0
1.1
43.8
66.4
u/l
—
5
19
17
117
1.47
0.72
1.5
1.4
—
—
—
0
0
5
26
1.93
0.71
2.0
1.4
0.9
1.1
g/l
—
5
26
215
2004
1.13
0.67
5.8
5.3
0.0
0.0
estimate
0.00
37
392
74
854
0.84
0.67
1.5
1.4
—
—
—
0
0
378
3657
1.17
0.67
4.1
3.9
1.2
1.3
mmol/l
0.11
347
3319
13
86
1.53
0.66
1.8
2.0
117.8
128.1
g/l
—
8
63
15
103
1.47
0.65
1.2
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
27
208
1.32
0.63
3.6
3.3
1.2
1.9
mmol/l
0.56
19
159
14
96
1.47
0.62
1.4
1.4
—
—
—
0
0
15
105
1.44
0.60
1.3
1.4
—
—
—
0
0
15
105
1.44
0.60
1.3
1.4
—
—
—
0
0
15
105
1.44
0.60
1.3
1.4
—
—
—
0
0
15
105
1.44
0.60
1.3
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
17
123
1.40
0.58
1.1
1.4
332.9
243.1
miu/ml
—
8
63
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
11
73
1.52
0.56
1.2
1.2
—
—
—
0
0
69
601
1.17
0.56
3.3
2.2
12.2
13.0
umol/l
0.59
64
548
8
55
1.46
0.56
1.3
1.5
—
—
—
0
0
10
66
1.53
0.53
1.2
1.5
—
—
—
0
0
10
67
1.50
0.50
1.4
1.6
—
—
—
0
0
8
117
0.68
0.46
1.5
1.2
—
—
—
0
0
18
138
1.32
0.46
1.9
2.4
4038.0
3597.6
u/l
—
9
53
63
556
1.15
0.45
3.5
2.2
2.4
2.4
g/l
0.07
58
513
59
519
1.16
0.44
3.8
2.2
19.5
21.9
%
0.92
50
445
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
44
379
1.18
0.43
1.6
2.1
—
—
—
0
0
17
131
1.31
0.42
4.2
3.6
24.3
25.0
mmol/l
0.84
17
125
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
17
132
1.30
0.41
1.9
1.9
—
—
—
0
0
19
150
1.28
0.41
1.8
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
89
1.36
0.38
2.0
2.3
0.5
0.4
u/ml
—
5
57
14
107
1.32
0.37
1.6
2.7
—
—
—
0
0
15
116
1.30
0.37
1.3
1.5
—
—
—
0
0
19
154
1.24
0.34
1.3
2.2
—
—
—
0
0
6
47
1.28
0.32
1.3
1.5
—
—
—
0
0
115
1078
1.09
0.31
1.7
1.6
1.3
1.3
mmol/l
0.80
103
916
22
184
1.21
0.31
1.3
1.8
—
—
—
0
0
20
238
0.83
0.29
1.2
1.3
—
—
—
0
0
8
62
1.30
0.28
1.1
1.1
—
—
—
0
0
95
892
1.08
0.25
4.2
4.2
1.0
1.0
kg/l
0.06
26
117
42
379
1.12
0.25
4.1
3.3
—
—
—
0
0
150
1435
1.07
0.24
4.1
3.6
38.1
58.9
ng/l
0.33
106
975
19
222
0.85
0.24
1.0
1.1
—
—
—
0
0
13
106
1.23
0.23
1.3
1.1
—
—
—
0
0
5
41
1.22
0.22
1.6
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
12
145
0.82
0.21
1.3
1.4
—
—
—
0
0
46
422
1.10
0.21
1.8
2.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
25
222
1.13
0.19
1.6
1.4
—
—
—
0
0
13
109
1.20
0.18
2.3
1.6
102.1
212.3
ug/l
1.58
13
100
7
59
1.19
0.18
1.0
1.4
—
—
—
0
0
7
59
1.19
0.18
1.0
1.4
—
—
—
0
0
7
60
1.17
0.18
1.0
1.4
—
—
—
0
0
5
67
0.74
0.17
1.0
1.6
—
—
—
0
0
49
457
1.08
0.16
6.0
4.9
9.7
2.7
ug/l
0.44
44
396
12
101
1.19
0.16
1.3
1.5
—
—
—
0
0
11
92
1.20
0.16
1.2
1.6
—
—
—
0
0
15
172
0.87
0.16
1.5
1.4
—
—
—
0
0
29
316
0.91
0.14
2.5
2.8
66.8
65.7
ml/min/173m2
0.07
18
132
150
1543
0.96
0.14
4.5
4.1
—
—
—
0
0
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
20
184
1.09
0.09
1.5
1.5
—
—
—
0
0
5
61
0.82
0.08
4.2
3.8
—
357.3
—
0
6
10
88
1.14
0.08
1.2
1.6
—
—
—
0
0
7
68
1.03
0.08
2.0
1.2
—
—
—
0
0
6
75
0.80
0.07
1.3
1.3
—
—
—
0
0
16
147
1.09
0.07
1.1
1.1
—
—
—
0
0
28
265
1.06
0.07
3.6
3.0
0.6
0.7
ug/l
0.41
18
184
8
94
0.85
0.06
1.3
1.7
—
—
—
0
0
29
296
0.98
0.00
1.4
1.7
—
—
—
0
0
37
364
1.02
0.00
4.5
4.3
20.3
21.2
%
0.10
18
186
13
134
0.97
0.00
2.1
1.9
—
—
—
0
0
12
117
1.03
0.00
1.2
4.4
—
2.3
—
0
12
23
234
0.98
0.00
5.6
7.1
23.9
24.9
mmol/l
0.33
17
222
15
147
1.02
0.00
1.1
1.1
—
—
—
0
0
13
128
1.02
0.00
1.5
1.6
—
215.0
—
0
8
10
101
0.99
0.00
1.1
1.3
—
—
—
0
0
116
1164
1.00
0.00
4.5
3.8
13.0
6.4
mg/mmol
0.35
74
684
0
8
0.00
0.00
0.0
1.0
—
26.3
—
0
8
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
57
0.88
0.00
1.0
1.3
—
—
—
0
0
6
60
1.00
0.00
1.0
1.4
—
—
—
0
0
6
59
1.02
0.00
1.0
1.4
—
—
—
0
0
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
0.00
2.0
3.3
—
3515.9
—
0
8
8
81
0.99
0.00
1.5
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
6
60
1.00
0.00
1.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: DIS_THYROID_OTH – Other disorders of thyroid
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).